EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition

Mei Li, Daoping Wang, Qing Li, Fang Luo, Ting Zhong, Hongshan Wu, Liang Xiong, Meitao Yuan, Mingzhi Su, Yanhua Fan

International Journal of Molecular Sciences · 06.04.2023 · 24 (7) · 6851

DOI: 10.3390/ijms24076851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.04.2023. Verfasst von Mei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. Hauptthemen laut MEDLINE: Quinazolines, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merit-based Funding Program for Innovation and Entrepreneurship of High-level Overseas Talents of Guizhou Province, Natural Science Foundation of Guizhou Provincial Science and Technology Projects, Science and Technology Plan Project of Guizhou Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant expression of the phosphatidylinositol 3-kinase (PI3K) signalling pathway is often associated with tumourigenesis, progression and poor prognosis. Hence, PI3K inhibitors have attracted significant interest for the treatment of cancer. In this study, a series of new 6-(imidazo[1,2-a]pyridin-6-yl)quinazoline derivatives were designed, synthesized and characterized by 1H NMR, 13C NMR and HRMS spectra analyses. In the in vitro anticancer assay, most of the synthetic compounds showed submicromolar inhibitory activity against various tumour cell lines, among which 13k is the most potent compound with IC50 values ranging from 0.09 μΜ to 0.43 μΜ against all the tested cell lines. Moreover, 13k induced cell cycle arrest at G2/M phase and cell apoptosis of HCC827 cells by inhibition of PI3Kα with an IC50 value of 1.94 nM. These results suggested that compound 13k might serve as a lead compound for the development of PI3Kα inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinazolinesAntineoplastic AgentsMolecular StructureStructure-Activity RelationshipPhosphatidylinositol 3-KinasesDrug Screening Assays, AntitumorCell ProliferationCell Line, TumorDrug Design

Stichwörter der Autor:innen

PI3Kα inhibitorcell apoptosiscell cycle arrestimidazo[1,2-a]pyridinequinazoline

Substanzen

QuinazolinesPhosphatidylinositol 3-KinasesAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China.
  • The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China.

Förderung

  • Merit-based Funding Program for Innovation and Entrepreneurship of High-level Overseas Talents of Guizhou Province
  • Natural Science Foundation of Guizhou Provincial Science and Technology Projects
  • Science and Technology Plan Project of Guizhou Province, China
  • National Natural Science Foundation of China

Zitieren

APA

Li, M., Wang, D., Li, Q., Luo, F., Zhong, T., Wu, H., Xiong, L., Yuan, M., Su, M., & Fan, Y. (2023). Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition. International Journal of Molecular Sciences, 24(7), 6851. https://doi.org/10.3390/ijms24076851

Vancouver

Li M, Wang D, Li Q, Luo F, Zhong T, Wu H, et al. Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition. International Journal of Molecular Sciences. 2023;24(7):6851. doi:10.3390/ijms24076851

BibTeX
@article{Li2023,
  author = {Li, Mei and Wang, Daoping and Li, Qing and Luo, Fang and Zhong, Ting and Wu, Hongshan and Xiong, Liang and Yuan, Meitao and Su, Mingzhi and Fan, Yanhua},
  title = {Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {6851},
  doi = {10.3390/ijms24076851}
}
Kostenlos starten →